C12N 2770/32722
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2770/32722 (New viral proteins or individual genes, new structural or functional aspects of) appears on 43 US grants and 52 published applications in this corpus.
Search patents in C12N- Granted patents
- 43
- Published applications
- 52
- Assignees
- 36
- Inventors
- 144
- Latest grant
- 22 Jun 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 4 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 5 | 0 |
| 2000 | 4 | 0 |
| 2001 | 2 | 1 |
| 2002 | 2 | 6 |
| 2003 | 2 | 5 |
| 2004 | 1 | 8 |
| 2005 | 4 | 2 |
| 2006 | 0 | 2 |
| 2007 | 2 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 2 |
| 2010 | 1 | 2 |
| 2011 | 2 | 1 |
| 2012 | 1 | 1 |
| 2013 | 0 | 0 |
| 2014 | 2 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 3 |
| 2017 | 0 | 2 |
| 2018 | 3 | 2 |
| 2019 | 4 | 2 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 2 |
| 2024 | 0 | 3 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Human rhinovirus vaccine22 Jun 2021US 11,040,095 B2Glaxosmithkline Biologicals SA
- Immunogenic rhinovirus peptides3 Dec 2019US 10,493,145 B2Glaxosmithkline Biologicals SA
- Rhinovirus C immunogenic peptides1 Oct 2019US 10,428,116 B2Purdue Research Foundation
- Compositions and methods for preventing and treating rhinovirus infections30 Jul 2019US 10,363,299 B2Benaroya Research Institute at Virginia Mason
- Adapted rhinovirus C9 Apr 2019US 10,253,300 B2Wisconsin Alumni Research Foundation
- Rhinovirus mrna vaccine7 May 2026US 2026/0124291 A1Sanofi Pasteur Limited
- Rhinovirus Vaccine20 Feb 2025US 2025/0057933 A1IP2Ipo Innovations Limited
- General affinity epitope polypeptide for human rhinovirus, and antibody and uses thereof24 Oct 2024US 2024/0350615 A1Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
- Compositions and methods of use for human rhinoviruses12 Sep 2024US 2024/0299477 A1
- Systems and methods for protein expression2 May 2024US 2024/0141373 A1Excepgen Inc.
Most cited
By later US patents
- Composition for introducing nucleic acid complexes into higher eucaryotic cells257US 5,547,932 ABoehringer Ingelheim International GmbH · 1996
- Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes185US 5,316,931 ABiosource Genetics Corporation · 1994
- Recombinant plant viral nucleic acids105US 5,589,367 ABiosource Technologies, Inc. · 1996
- Recombinant plant viral nucleic acids86US 5,866,785 ABiosource Technologies, Inc. · 1999
- Recombinant plant viral nucleic acids73US 5,889,190 ABiosource Technologies, Inc. · 1999